FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Why Drug Firms Get More Fraud Probes than Others

[ Price : $8.95]

Michael Loucks, chief prosecutor on significant whistleblower cases against pharmaceutical companies, predicts a surge in health c...

Will DARRTS Make FDA Less Transparent?

[ Price : $8.95]

Attorney Kurt Karst calls on FDA to give a fuller explanation of how CDERs new DARRTS document system will affect generic drug app...

Innovative Drugs Get Quicker Reviews: Parexel

[ Price : $8.95]

Parexel Consulting says FDA review times seem to favor truly innovative new drugs whose NDAs are submitted by companies that work ...

Former FDA Commish Von E Joins Newts Health Center

[ Price : $8.95]

Former FDA commissioner Andrew von Eschenbach joins Newt Gingrichs Center for Health Transformation as leader of the groups 21st C...

Sanofi-Aventis Wants ICH Biomarker Guidance Clarification

[ Price : $8.95]

Sanofi-Aventis asks FDA to clarify several aspects of a draft ICH guidance on genomic biomarkers.

Study Violations Found at MS Research Center

[ Price : $8.95]

CBER warns the Multiple Sclerosis Research Center of New York over multiple violations of regulations governing non-clinical studi...

GSK Stresses Patient Care in CME Funding

[ Price : $8.95]

GlaxoSmithKline says it is restricting CME funding to certain types of providers and only to programs that will demonstrably impro...

FDA Clears Maquet Intra-aortic Balloon Catheter

[ Price : $8.95]

FDA clears a Maquet Cardiovascular 510(k) for the Mega 8Fr 50cc intra-aortic balloon catheter.

FDA OKs Smaller Cypher Stent

[ Price : $8.95]

FDA approves a smaller version of Cordis Cypher Sirolimus-eluting Coronary Stent.

12 Months Later, FDA Needs to Crown its Prince

[ Price : $8.95]

Consulting editor John Scharmann analyzes the role of FDAs associate commissioner for regulatory affairs over the years, and says ...